Malignant Pleural Effusion Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
The Malignant Pleural Effusion pipeline market report provides a comprehensive overview of the therapeutics under development for Malignant Pleural Effusion, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Malignant Pleural Effusion and features dormant and discontinued projects.
Key Targets in the Malignant Pleural Effusion Pipeline Drugs Market
In the Malignant Pleural Effusion pipeline drugs market, the key targets are Dihydrofolate Reductase, Tubulin, Tumor Necrosis Factor Receptor Superfamily Member 10A, and Tumor Necrosis Factor Receptor Superfamily Member 10B.
For more target insights, download a free report sample
Key MoA in the Malignant Pleural Effusion Pipeline Drugs Market
The key MoA in the Malignant Pleural Effusion pipeline drugs market report are Dihydrofolate Reductase Inhibitor Tubulin Inhibitor, Tumor Necrosis Factor Receptor Superfamily Member 10A Agonist, and Tumor Necrosis Factor Receptor Superfamily Member 10B Agonist.
To get more insights on key MoA, download a free sample report
Malignant Pleural Effusion Pipeline Drugs Market Segmentation by RoA
The key routes of administration in the Malignant Pleural Effusion pipeline drug market are intrapleural, intraperitoneal, intravesical, inhalational, intralesional, intratumor, intravenous, and intravenous drip. Intrapleural has the maximum number of pipeline products.
Malignant Pleural Effusion Pipeline Drugs Market Analysis, by RoA
To get more insights on key RoA, download a free sample report
Key Molecule Types in the Malignant Pleural Effusion Pipeline Drugs Market
The key molecule types in the Malignant Pleural Effusion pipeline drugs market are small molecule, oncolytic virus, fusion protein, and recombinant protein. Small molecule has the highest number of pipeline products.
Malignant Pleural Effusion Pipeline Drugs Market, by Molecule Types
To get more insights on key molecule types, download a free sample report
Major Companies in the Malignant Pleural Effusion Pipeline Drugs Market
The major companies in the Malignant Pleural Effusion pipeline drugs market are Amgen Inc, BioSyngen Pte Ltd, Clover Biopharmaceuticals Ltd, Genelux Corp, Gongwin Biopharm Holdings Co Ltd, Hubei Soundny, Bio-Tech Co Ltd, Jiangxi Jemincare Group Co Ltd, Lipac Oncology LLC, RS Oncology LLC, and Simcere Pharmaceutical Group Ltd.
Malignant Pleural Effusion Pipeline Drugs Market, by Major Companies
For more company insights, download a free sample report
Malignant Pleural Effusion Pipeline Drugs Market Overview
Key Targets | Dihydrofolate Reductase, Tubulin, Tumor Necrosis Factor Receptor Superfamily Member 10A, and Tumor Necrosis Factor Receptor Superfamily Member 10B |
Key Mechanisms of action | Dihydrofolate Reductase Inhibitor, Tubulin Inhibitor, Tumor Necrosis Factor Receptor Superfamily Member 10A Agonist, and Tumor Necrosis Factor Receptor Superfamily Member 10B Agonist |
Key Routes of Administration | Intrapleural, Intraperitoneal, Intravesical, Inhalational, Intralesional, Intratumor, Intravenous, and Intravenous Drip |
Key Molecule Types | Small Molecule, Oncolytic Virus, Fusion Protein, and Recombinant Protein |
Major Companies | Amgen Inc, BioSyngen Pte Ltd, Clover Biopharmaceuticals Ltd, Genelux Corp, Gongwin Biopharm Holdings Co Ltd, Hubei Soundny, Bio-Tech Co Ltd, Jiangxi Jemincare Group Co Ltd, Lipac Oncology LLC, RS Oncology LLC, and Simcere Pharmaceutical Group Ltd |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Malignant Pleural Effusion
- The pipeline guide reviews pipeline therapeutics for Malignant Pleural Effusion by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Malignant Pleural Effusion therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Malignant Pleural Effusion therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Malignant Pleural Effusion
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with a potentially strong product portfolio and create effective counter strategies to gain a competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Malignant Pleural Effusion
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding Malignant Pleural Effusion pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
BioSyngen Pte Ltd
Clover Biopharmaceuticals Ltd
Genelux Corp
Gongwin Biopharm Holdings Co Ltd
Hubei Soundny Bio-Tech Co Ltd
Jiangxi Jemincare Group Co Ltd
Lipac Oncology LLC
RS Oncology LLC
Simcere Pharmaceutical Group Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key targets in the Malignant Pleural Effusion pipeline drug market?
In the Malignant Pleural Effusion pipeline drugs market the key targets are Dihydrofolate Reductase, Tubulin, Tumor Necrosis Factor Receptor Superfamily Member 10A, and Tumor Necrosis Factor Receptor Superfamily Member 10B.
-
What are the key mechanisms of action in the Malignant Pleural Effusion pipeline drugs market?
In the Malignant Pleural Effusion pipeline drugs market the key mechanisms of action are Dihydrofolate Reductase Inhibitor, Tubulin Inhibitor, Tumor Necrosis Factor Receptor Superfamily Member 10A Agonist, and Tumor Necrosis Factor Receptor Superfamily Member 10B Agonist.
-
What are the key routes of administration in the Malignant Pleural Effusion pipeline drugs market?
The key routes of administration in the Malignant Pleural Effusion pipeline drug market are Intrapleural, Intraperitoneal, Intravesical, Inhalational, Intralesional, Intratumor, Intravenous, and Intravenous Drip. Intrapleural has the maximum number of pipeline products.
-
What are the key molecule types in the Malignant Pleural Effusion pipeline drugs market?
The key molecule types in the Malignant Pleural Effusion pipeline drug market are Small Molecule, Oncolytic Virus, Fusion Protein, and Recombinant Protein.
-
What are the major companies in the Malignant Pleural Effusion pipeline drugs market?
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.